Climate change could exacerbate respiratory disease deaths during warm seasons

Global warming caused by climate change could exacerbate the burden of inpatient mortality from respiratory diseases during the warm season.

Perspective’s early data on lead-based radiopharma asset suggest lower dose did better

In early-stage trials called dose escalation studies, drug developers usually want to test progressively higher doses of their therapies. Not Perspective Therapeutics. The radiopharma biotech

October 12, 2024

ARS hits roadblock for neffy approval as FDA requests additional study – Pharmaceutical Technology

Following the news, which was announced on 19 September, ARS’s stock dropped by over 50% in pre-market trading. Image Credit: Alexandr Shatilov / Shutterstock. The

September 20, 2023

Study reveals sharp increase in emergency department visits due to water beads

Researchers from the Center for Injury Research and Policy and Central Ohio Poison Center at Nationwide Children’s Hospital have found more than an estimated 8,000

August 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.